Small Cell Lung Cancer: What is the Role of IO Therapy in the Frontline Setting?
A brief review of the role that immunotherapy agents play in the frontline management of patients with small cell lung cancer.
Source: onclive.com
Ipi Nivo News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ipi Nivo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ipi Nivo Today - Breaking & Trending Today
Relapsed/Refractory Clear Cell RCC: Novel Treatment Strategies
Switching their focus to relapsed/refractory advanced clear cell renal cell carcinoma, key opinion leaders review treatment options in this setting.
Source: onclive.com
Role of Combination Immunotherapy in Metastatic Renal Cell Carcinoma
Key opinion leaders in the field of renal cell carcinoma management discuss the advent of combination immunotherapy in patients with metastatic disease.
Source: onclive.com
Scenario 1: A 47-Year-Old Man With Intermediate Risk Metastatic RCC
Expert perspectives on a patient scenario of intermediate risk metastatic renal cell carcinoma and corresponding management with combination immunotherapy.
Source: onclive.com
Selecting Therapy for Advanced NSCLC Based on PDL1 and NGS Testing
Shared insight on the value that molecular testing and PDL1 testing, respectively, have on determining optimal therapy for patients with advanced non–small cell lung cancer.
Source: onclive.com